Evidence map›Paper›PMID 38440143›Full record

ArticleFrontiers in microbiology2024

Zhong Feng, Hui Li, Yajie Hao, Chang Peng, Ling Ou, Junwei Jia, Mingjin Xun, Yuanjing Zou, Meiyun Chen, Guimin Zhang and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Novel anti-virulence strategy againstFrontiers in microbiology · 2026
    Article
  3. Antimicrobial and Synergistic Activity of Metformin AgainstThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  4. Article
  5. Article
  6. Therapeutic advances and future directions inFrontiers in microbiology · 2025
    Review
  7. Helile formula from "Tai ping sheng hui fangFrontiers in cellular and infection microbiology · 2025
    Article
  8. Antibody immune responses and causal relationships in four immune skin diseases: Evidence from Mendelian randomization and Bayesian Weighting (Antibody Responses in Skin Diseases: MR & Bayesian).Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  9. Cancers · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Zhong Feng *School of Pharmaceutical Sciences, Sun Yat-sen University, Shenzhen, China.
Hui Li *State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
Yajie HaoState Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
Chang PengSchool of Pharmaceutical Sciences, Sun Yat-sen University, Shenzhen, China.
Ling OuSchool of Pharmaceutical Sciences, Sun Yat-sen University, Shenzhen, China.
Junwei JiaState Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
Mingjin XunState Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
Yuanjing ZouSchool of Pharmaceutical Sciences, Sun Yat-sen University, Shenzhen, China.
Meiyun ChenSchool of Pharmaceutical Sciences, Sun Yat-sen University, Shenzhen, China.
Guimin ZhangState Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi, China.
Meicun YaoSchool of Pharmaceutical Sciences, Sun Yat-sen University, Shenzhen, China.
Sun Yat-sen University · CNLuye Pharma (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Chemical components of HZQYF were studied using UHPLC-MS/MS and HPLC. Broth microdilution method and agar dilution method were used to evaluate HZQYF's antibacterial activity. The effects of HZQYF on expression of adhesion genes ( Results: Minimum inhibitory concentration (MIC) values of the formula against Conclusion: Present studies confirmed that HZQYF had promising

Indexed as

antibacterial activityHelicobacter pyloriHezi Qingyou Formulain vitromechanism of action

Identifiers

PMID38440143
PMCPMC10910045
OpenAlexW4391929245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.